Induction by synthetic peptides of broadly reactive, type-specific neutralizing antibody to poliovirus type 3.
A region of virus capsid protein VP1 located 89-100 amino acids from the N-terminus has been proposed to comprise a major antigenic site involved in the neutralization of poliovirus type 3. Synthetic peptides 10-18 amino acids in length, containing all or part of this sequence, were tested for their ability to induce antiviral antibodies. Rabbits, but not guinea pigs or mice, immunized with the most active peptide, developed hightitered, type-specific, neutralizing antibodies for a wide range of poliovirus type 3 strains. Consistent with the broad type specificity of the antibody response was the observation that amino acids 89-100 of VP1 are highly conserved among different poliovirus type 3 strains. This sequence thus appears to provide, at least in part, a molecular basis for serotype antigenic specificity. Individual amino acids from 93 to 98 within this sequence were shown to be important for the neutralization of virus by antipeptide sera by examination of the ability of the sera to neutralize laboratory-derived poliovirus type 3 mutants with known single amino acid substitutions in the proposed antigenic site.
Ferguson
M
M
Evans
D M
DM
Magrath
D I
DI
Minor
P D
PD
Almond
J W
JW
Schild
G C
GC
D000595:Amino Acid Sequence; D000818:Animals; D000914:Antibodies, Viral; D000917:Antibody Formation; D002213:Capsid / Q000276:immunology*; D000939:Epitopes; D006168:Guinea Pigs; D005779:Immunodiffusion; D051379:Mice; D008807:Mice, Inbred BALB C; D009842:Oligopeptides / Q000138:chemical synthesis / Q000276:immunology*; D017955:Poliovirus / Q000276:immunology*; D011817:Rabbits; D013045:Species Specificity
D000914:Antibodies, Viral; D000939:Epitopes; D009842:Oligopeptides